Sign inJoin waitlistJoin the waitlist

GG

Gregory Gordon

Internal Medicine

Credentials: ·

History

Internal Medicine

Research

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
The Lancet Diabetes & Endocrinology · 2020 · 372 citations
Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome
Diabetes · 2020 · 111 citations
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design
Contemporary Clinical Trials Communications · 2021 · 34 citations

JY
Jack Yanovski
2 papers
RH
Robert Haws
2 papers
Elisabeth Davis
1 paper
James Swain
1 paper
Joan Han
1 paper
SB
Sheila Brady
1 paper
Wendy Chung
1 paper